## **Core Concept**
The patient's symptoms of recurrent abortions and pain in the calves suggest a condition related to coagulation or thrombosis. The underlying principle here involves the identification of a disorder that leads to an increased tendency to form blood clots (thrombophilia), which can cause recurrent fetal loss and venous thromboembolism.

## **Why the Correct Answer is Right**
The correct answer, **Antithrombin III**, is a crucial protein that inhibits the coagulation cascade by inactivating thrombin and other clotting factors. A deficiency in antithrombin III leads to a hypercoagulable state, increasing the risk of venous thromboembolism and recurrent thrombosis. This condition can manifest as recurrent deep vein thrombosis (which might cause pain in the calves) and can also lead to complications in pregnancy, such as recurrent abortions, due to placental insufficiency caused by thrombosis.

## **Why Each Wrong Option is Incorrect**
- **Option A: Protein C** - While a deficiency in protein C can also lead to a hypercoagulable state and increase the risk of thrombosis, it typically presents with warfarin-induced skin necrosis and not specifically with the combination of recurrent abortions and calf pain as primary manifestations.
- **Option B: Protein S** - Similar to protein C, a deficiency in protein S can lead to increased risk of thrombosis. However, its deficiency is also more commonly associated with a similar presentation to protein C deficiency and is often identified in the context of a hypercoagulable workup.
- **Option D: Factor V Leiden** - This is a mutation in the factor V gene leading to a form of thrombophilia. While it does increase the risk of thrombosis, it is less commonly associated directly with calf pain and more with an increased risk of venous thromboembolism.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that antithrombin III deficiency is a rare but severe form of thrombophilia. Patients with this deficiency are at a high risk of thrombotic events and may require long-term anticoagulation therapy. The association of recurrent fetal loss with antithrombin III deficiency highlights the importance of thrombophilia screening in patients with recurrent miscarriages.

## **Correct Answer:** . **Antithrombin III**